Bharat Book

Inflammatory Bowel Disease - Pipeline Review, H2

Press Release   •   Dec 09, 2013 11:31 IST

Dec 09, 2013 : Bharat Book Bureau presents the new report, on 'Inflammatory Bowel Disease - Pipeline Review, H2 2013  also reviews key players involved in the therapeutic development for Inflammatory Bowel Disease. Inflammatory Bowel Disease - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Inflammatory Bowel Disease.
- A review of the Inflammatory Bowel Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Inflammatory Bowel Disease pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Inflammatory Bowel Disease.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Inflammatory Bowel Disease pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Companies Mentioned

Johnson & Johnson
Boehringer Ingelheim GmbH
Sanofi-Aventis
Athersys, Inc.
GlaxoSmithKline plc
Biotec Pharmacon ASA
Emergent BioSolutions Inc.
BioLineRx, Ltd.
TiGenix NV
ASKA Pharmaceutical Co., Ltd
Eisai Co., Ltd.
Mitsubishi Tanabe Pharma Corporation
Norgine Limited
Ono Pharmaceutical Co., Ltd.
Rigel Pharmaceuticals, Inc.
Santarus, Inc.
Paratek Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc.
4SC AG
Addex Pharmaceuticals
AlbireoPharma
iCo Therapeutics Inc.
Karo Bio
Basilea Pharmaceutica Ltd.
NeuroSearch A/S
Compugen Ltd.
Ore Pharmaceuticals Inc
Cosmo Pharmaceuticals S.p.A
Pluristem Therapeutics Inc.
Galapagos NV
Synta Pharmaceuticals Corp.
Sucampo Pharmaceuticals, Inc.
MetrioPharm AG
Advinus Therapeutics Pvt. Ltd.
Affimed Therapeutics AG
ActogeniX NV
Am-Pharma B.V.
Jenrin Discovery, Inc.
Upsher-Smith Laboratories, Inc.
Ventria Bioscience

Table of contents :

Table of Contents 2
Introduction 6
Inflammatory Bowel Disease Overview 7
Therapeutics Development 8
Inflammatory Bowel Disease Therapeutics under Development by Companies 10
Inflammatory Bowel Disease Therapeutics under Investigation by Universities/Institutes 17
Mid Clinical Stage Products 19
Early Clinical Stage Products 20
Discovery and Pre-Clinical Stage Products 21
Inflammatory Bowel Disease Therapeutics - Products under Development by Companies 22
Inflammatory Bowel Disease Therapeutics - Products under Investigation by Universities/Institutes 30
Companies Involved in Inflammatory Bowel Disease Therapeutics Development 31
Inflammatory Bowel Disease - Therapeutics Assessment 104
Drug Profiles 109
Inflammatory Bowel Disease Therapeutics - Drug Profile Updates 278
Inflammatory Bowel Disease Therapeutics - Discontinued Products 312
Inflammatory Bowel Disease Therapeutics - Dormant Products 313
Inflammatory Bowel Disease - Product Development Milestones 319
Appendix 326

List of Tables
Number of Products Under Development for Inflammatory Bowel Disease, H2 2013 23
Products under Development for Inflammatory Bowel Disease - Comparative Analysis, H2 2013 24
Number of Products under Development by Companies, H2 2013 26
Number of Products under Development by Companies, H2 2013 (Contd..1) 27
Number of Products under Development by Companies, H2 2013 (Contd..2) 28
Number of Products under Development by Companies, H2 2013 (Contd..3) 29
Number of Products under Development by Companies, H2 2013 (Contd..4) 30
Number of Products under Development by Companies, H2 2013 (Contd..5) 31
Number of Products under Investigation by Universities/Institutes, H2 2013 33
Comparative Analysis by Mid Clinical Stage Development, H2 2013 34
Comparative Analysis by Early Clinical Stage Development, H2 2013 35
Comparative Analysis by Discovery and Pre-Clinical Stage Development, H2 2013 36
Products under Development by Companies, H2 2013 37
Products under Development by Companies, H2 2013 (Contd..1) 38
Products under Development by Companies, H2 2013 (Contd..2) 39
Products under Development by Companies, H2 2013 (Contd..3) 40
Products under Development by Companies, H2 2013 (Contd..4) 41
Products under Development by Companies, H2 2013 (Contd..5) 42
Products under Development by Companies, H2 2013 (Contd..6) 43
Products under Development by Companies, H2 2013 (Contd..7) 44
Products under Investigation by Universities/Institutes, H2 2013 45
Johnson & Johnson, H2 2013 46
Boehringer Ingelheim GmbH, H2 2013 47
Sanofi-Aventis, H2 2013 48
Athersys, Inc., H2 2013 49
GlaxoSmithKline plc, H2 2013 50
Biotec Pharmacon ASA, H2 2013 51
Emergent BioSolutions Inc., H2 2013 52
BioLineRx, Ltd., H2 2013 53
TiGenix NV, H2 2013 54
ASKA Pharmaceutical Co., Ltd, H2 2013 55
Eisai Co., Ltd., H2 2013 56
Mitsubishi Tanabe Pharma Corporation, H2 2013 57
Norgine Limited, H2 2013 58
Ono Pharmaceutical Co., Ltd., H2 2013 59
Rigel Pharmaceuticals, Inc., H2 2013 60
Santarus, Inc., H2 2013 61
Paratek Pharmaceuticals, Inc., H2 2013 62
Onyx Pharmaceuticals, Inc., H2 2013 63
4SC AG, H2 2013 64
Addex Pharmaceuticals, H2 2013 65
AlbireoPharma, H2 2013 66
iCo Therapeutics Inc., H2 2013 67
Karo Bio, H2 2013 68
Basilea Pharmaceutica Ltd., H2 2013 69
NeuroSearch A/S, H2 2013 70
Compugen Ltd., H2 2013 71
Ore Pharmaceuticals Inc, H2 2013 72
Cosmo Pharmaceuticals S.p.A, H2 2013 73
Pluristem Therapeutics Inc., H2 2013 74
Galapagos NV, H2 2013 75
Synta Pharmaceuticals Corp., H2 2013 76
Sucampo Pharmaceuticals, Inc., H2 2013 77
MetrioPharm AG, H2 2013 78
Advinus Therapeutics Pvt. Ltd., H2 2013 79
Affimed Therapeutics AG, H2 2013 80
ActogeniX NV, H2 2013 81

For more information kindly visit : http://www.bharatbook.com/Healthcare-market-research-reports/Inflammatory-Bowel-Disease-Pipeline-Review-H2-20131.html

Related link :  http://www.bharatbook.com/market-research-report/pharmaceuticals-and-healthcare.html

About Bharat Book Bureau:

Bharat Book Bureau is the leading market research information provider for market research reports, , company profiles, industry analysis , country reports , business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.

In case the reports don't match your requirement then we can do a specialized Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us in a unique position to take up Custom Research demands of yourself.

Contact us at :

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Toll Free No for USA/Canada : 1-866-279-8368
Email: info@bharatbook.com 
Website: www.bharatbook.com 
Follow us on twitter: https://twitter.com/researchbook 
Follow us on linked in : http://www.linkedin.com/company/bharat-book-bureau 
Our Blog : http://blog.bharatbook.com/ 


Bharat Book Bureau, the leading market research information aggregator provides market research reports, company profiles, country reports, newsletters, and online databases for the past twenty four years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world.